Leadership at the Centers for Medicare and Medicaid Services is working with states to develop plans to use the $50 billion ...

In an exclusive interview with Yahoo Finance's Decoding Retirement podcast, Mehmet Oz, the administrator of the Centers for ...

Dr. Mehmet Oz, administrator for the Centers for Medicare & Medicaid Services, discusses the Trump administration’s efforts ...

The latest public gaffe came as the Trump administration is encouraging millions of Americans to transfer their personal ...

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach ...

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

Rather than push people off Medicaid, President Donald Trump’s so-called “big, beautiful bill” — now law — will “move more ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

Dr. Mehmet Oz is the administrator of the Centers for Medicare & Medicaid Services. Kim Brandt is the deputy administrator and chief operating officer.

When President-elect Donald Trump picked Dr. Mehmet Oz for a powerful executive branch job overseeing Medicare, incoming Senate Finance Committee Chair Mike Crapo, R-Idaho, quickly praised the TV ...

So, shame on Dr. Oz for suggesting that Medicaid and Medicare recipients should avoid even the most meager of indulgences.